Skip to main content
. 2022 Jan 22;12(2):187. doi: 10.3390/biom12020187

Figure 3.

Figure 3

Docetaxel and abiraterone cell viability assays in the miR-182-5p transfected DU145 cells. (a) Cell viability in the docetaxel treated cells with ectopic expression of miR-182-5p; (b) Cell viability in the abiraterone treated cells transfected with miR-182-5p inhibitor. Drug exposure time of 72 h. NC = negative control; inh = inhibitor. Statistically significance * p < 0.05; *** p < 0.001.